Beta Drugs Limited — Others, 19-10-2024: Shareholders meeting

Beta Drugs Limited will hold an Extraordinary General Meeting (EGM) on November 12, 2024, to discuss several key items: the proposed increase of its authorized share capital from ₹10 crores to ₹10.5 crores, approval for the issuance of 100 equity shares and 707,651 convertible debentures on a preferential basis, and the grant of special rights to Healthquad Fund II and Inti Capital VCC. Voting can be done through remote e-voting from November 9 to November 11, 2024.